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Résumé en
anglais
Objectives:To evaluate the inter-laboratory reproducibility of blood test for liver
fibrosis: FibroMeter, Fibrotest, APRI and their composites variables. Design and
methods: Four studies, including 147 patients, were performed: study #1 included 2
metachronous blood samples and 2 laboratories; studies #2, #3 and #4 included
synchronous samples with assays delayed at day 1 in 12 laboratories, at day 0 in 10
laboratories and at day 0 or 1 in 2 laboratories, respectively. Agreement was
evaluated by the intraclass correlation coefficient (ric). Results: In studies #1, #2
and #4, ric for FibroMeter was 0.893, 0.942 and 0.991, respectively. In study #3,
the ric were: FibroMeter: 0.963, Fibrotest: 0.984, APRI: 0.949. Large simulated
variations in composite variables had a weak impact on FibroMeter. Conclusions:
When blood marker limits are controlled, inter-laboratory agreement of blood tests
is excellent in clinical practice conditions. Blood tests are robust against the
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